• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

EphA3 通过上皮间质转化维持头颈部癌症的放射抗性。

EphA3 maintains radioresistance in head and neck cancers through epithelial mesenchymal transition.

机构信息

Department of Otolaryngology, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Republic of Korea.

Department of Biochemistry and Molecular Biology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.

出版信息

Cell Signal. 2018 Jul;47:122-130. doi: 10.1016/j.cellsig.2018.04.001. Epub 2018 Apr 10.

DOI:10.1016/j.cellsig.2018.04.001
PMID:29653204
Abstract

Radiotherapy is a well-established therapeutic modality used in the treatment of many cancers. However, radioresistance remains a serious obstacle to successful treatment. Radioresistance can cause local recurrence and distant metastases in some patients after radiation treatment. Thus, many studies have attempted to identify effective radiosensitizers. Eph receptor functions contribute to tumor development, modulating cell-cell adhesion, invasion, neo-angiogenesis, tumor growth and metastasis. However, the role of EphA3 in radioresistance remains unclear. In the current study, we established a stable radioresistant head and neck cancer cell line (AMC HN3R cell line) and found that EphA3 was expressed predominantly in the radioresistant head and neck cancer cell line through DNA microarray, real time PCR and Western blotting. Additionally, we found that EphA3 was overexpressed in recurrent laryngeal cancer specimens after radiation therapy. EphA3 mediated the tumor invasiveness and migration in radioresistant head and neck cancer cell lines and epithelial mesenchymal transition- related protein expression. Inhibition of EphA3 enhanced radiosensitivity in the AMC HN 3R cell line in vitro and in vivo study. In conclusion, our results suggest that EphA3 is overexpressed in radioresistant head and neck cancer and plays a crucial role in the development of radioresistance in head and neck cancers by regulating the epithelial mesenchymal transition pathway.

摘要

放射疗法是一种成熟的治疗方式,用于治疗许多癌症。然而,放射抗性仍然是成功治疗的严重障碍。放射抗性可导致一些患者在放射治疗后局部复发和远处转移。因此,许多研究试图确定有效的放射增敏剂。Eph 受体功能有助于肿瘤的发展,调节细胞-细胞黏附、侵袭、新生血管生成、肿瘤生长和转移。然而,EphA3 在放射抗性中的作用尚不清楚。在本研究中,我们建立了一个稳定的耐放射头颈癌细胞系(AMC HN3R 细胞系),通过 DNA 微阵列、实时 PCR 和 Western blot 发现 EphA3 在耐放射头颈癌细胞系中表达明显。此外,我们发现 EphA3 在放射治疗后的复发性喉癌标本中过表达。EphA3 介导耐放射头颈癌细胞系的肿瘤侵袭和迁移以及上皮间质转化相关蛋白表达。抑制 EphA3 可增强体外和体内 AMC HN3R 细胞系的放射敏感性。总之,我们的研究结果表明,EphA3 在耐放射头颈癌中过度表达,并通过调节上皮间质转化途径在头颈部癌症的放射抗性发展中起关键作用。

相似文献

1
EphA3 maintains radioresistance in head and neck cancers through epithelial mesenchymal transition.EphA3 通过上皮间质转化维持头颈部癌症的放射抗性。
Cell Signal. 2018 Jul;47:122-130. doi: 10.1016/j.cellsig.2018.04.001. Epub 2018 Apr 10.
2
EPHA3 Contributes to Epigenetic Suppression of PTEN in Radioresistant Head and Neck Cancer.Epha3 促进放射性耐药头颈癌细胞中 ptenc 的表观遗传抑制。
Biomolecules. 2021 Apr 18;11(4):599. doi: 10.3390/biom11040599.
3
Pretreatment microRNA Expression Impacting on Epithelial-to-Mesenchymal Transition Predicts Intrinsic Radiosensitivity in Head and Neck Cancer Cell Lines and Patients.预处理 microRNA 表达对上皮-间充质转化的影响预测头颈部癌细胞系和患者的内在放射敏感性。
Clin Cancer Res. 2015 Dec 15;21(24):5630-8. doi: 10.1158/1078-0432.CCR-15-0454. Epub 2015 Aug 11.
4
Periostin Plays a Key Role in Radioresistance of Head and Neck Cancer Cells Epithelial-to-Mesenchymal Transition.骨膜蛋白在头颈部癌细胞上皮-间质转化中的放射抵抗中起关键作用。
Anticancer Res. 2020 May;40(5):2627-2635. doi: 10.21873/anticanres.14233.
5
EPHA3 regulates the multidrug resistance of small cell lung cancer via the PI3K/BMX/STAT3 signaling pathway.EPHA3通过PI3K/BMX/STAT3信号通路调节小细胞肺癌的多药耐药性。
Tumour Biol. 2016 Sep;37(9):11959-11971. doi: 10.1007/s13277-016-5048-4. Epub 2016 Apr 21.
6
Attenuated LKB1-SIK1 signaling promotes epithelial-mesenchymal transition and radioresistance of non-small cell lung cancer cells.LKB1-SIK1信号通路减弱促进非小细胞肺癌细胞的上皮-间质转化和放射抗性。
Chin J Cancer. 2016 Jun 7;35:50. doi: 10.1186/s40880-016-0113-3.
7
Radiation-promoted CDC6 protein stability contributes to radioresistance by regulating senescence and epithelial to mesenchymal transition.辐射促进 CDC6 蛋白稳定性通过调节衰老和上皮间质转化来促进放射抵抗。
Oncogene. 2019 Jan;38(4):549-563. doi: 10.1038/s41388-018-0460-4. Epub 2018 Aug 29.
8
Radiotherapy-associated Furin Expression and Tumor Invasiveness in Recurrent Laryngeal Cancer.复发性喉癌中放疗相关的弗林蛋白酶表达与肿瘤侵袭性
Anticancer Res. 2016 Oct;36(10):5117-5125. doi: 10.21873/anticanres.11081.
9
Cancer stem cell related markers of radioresistance in head and neck squamous cell carcinoma.头颈部鳞状细胞癌中与放射抗性相关的癌症干细胞标志物
Oncotarget. 2015 Oct 27;6(33):34494-509. doi: 10.18632/oncotarget.5417.
10
Inhibition of epithelial-mesenchymal transition by cetuximab via the EGFR-GEP100-Arf6-AMAP1 pathway in head and neck cancer.西妥昔单抗通过EGFR-GEP100-Arf6-AMAP1途径抑制头颈癌中的上皮-间质转化
Head Neck. 2017 Mar;39(3):476-485. doi: 10.1002/hed.24626. Epub 2016 Nov 23.

引用本文的文献

1
Development of a specific anti-human EphA3 monoclonal antibody, EaMab-20, for flow cytometry.用于流式细胞术的特异性抗人EphA3单克隆抗体EaMab-20的研制。
Biochem Biophys Rep. 2025 Jul 4;43:102130. doi: 10.1016/j.bbrep.2025.102130. eCollection 2025 Sep.
2
Co-Delivery of siRNA and Docetaxel to Cancer Cells by NLC for Therapy.通过纳米脂质载体将小干扰RNA和多西他赛共同递送至癌细胞用于治疗
ACS Omega. 2024 Feb 27;9(10):11671-11685. doi: 10.1021/acsomega.3c09098. eCollection 2024 Mar 12.
3
Tristetraprolin regulates phagocytosis through interaction with CD47 in head and neck cancer.
在头颈癌中,Tristetraprolin通过与CD47相互作用调节吞噬作用。
Exp Ther Med. 2022 Jun 29;24(3):541. doi: 10.3892/etm.2022.11478. eCollection 2022 Sep.
4
Properties and gene expression profiling of acquired radioresistance in mouse breast cancer cells.小鼠乳腺癌细胞获得性放射抗性的特性及基因表达谱分析
Ann Transl Med. 2021 Apr;9(8):628. doi: 10.21037/atm-20-4667.
5
EPHA3 Contributes to Epigenetic Suppression of PTEN in Radioresistant Head and Neck Cancer.Epha3 促进放射性耐药头颈癌细胞中 ptenc 的表观遗传抑制。
Biomolecules. 2021 Apr 18;11(4):599. doi: 10.3390/biom11040599.
6
MUC1 confers radioresistance in head and neck squamous cell carcinoma (HNSCC) cells.黏蛋白 1 赋予头颈部鳞状细胞癌(HNSCC)细胞放射抵抗性。
Bioengineered. 2020 Dec;11(1):769-778. doi: 10.1080/21655979.2020.1791590.
7
Chelidonine enhances the antitumor effect of lenvatinib on hepatocellular carcinoma cells.白屈菜碱增强乐伐替尼对肝癌细胞的抗肿瘤作用。
Onco Targets Ther. 2019 Aug 19;12:6685-6697. doi: 10.2147/OTT.S215103. eCollection 2019.
8
ARQ-197 enhances the antitumor effect of sorafenib in hepatocellular carcinoma cells via decelerating its intracellular clearance.ARQ-197通过减缓索拉非尼在肝癌细胞内的清除来增强其抗肿瘤作用。
Onco Targets Ther. 2019 Feb 26;12:1629-1640. doi: 10.2147/OTT.S196713. eCollection 2019.